Eric Dobmeier
Directeur/Membre du Conseil chez ATARA BIOTHERAPEUTICS, INC.
Fortune : 394 328 $ au 30/04/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Srini Akkaraju Akkaraju | M | 56 |
Chinook Therapeutics U.S., Inc.
 Chinook Therapeutics U.S., Inc. Information Technology ServicesTechnology Services Chinook Therapeutics U.S., Inc. operates as a development stage company. The company is headquartered in Seattle, WA. | 21 ans |
| Eric Hyllengren | M | - | 6 ans | |
| Michelle Griffin | F | 58 | 5 ans | |
| Daniel Welch | M | 66 | 18 ans | |
| Pascal Touchon | M | 61 | 5 ans | |
| Carol Gallagher | M | 59 | 11 ans | |
| Jerel Davis | M | 47 |
Chinook Therapeutics U.S., Inc.
Chinook Therapeutics U.S., Inc. Information Technology ServicesTechnology Services Chinook Therapeutics U.S., Inc. operates as a development stage company. The company is headquartered in Seattle, WA. | 6 ans |
| Raymond Stevens | M | 60 | 5 ans | |
| Kenneth Hoberman | M | 59 | 11 ans | |
| Joanne Waldstreicher | M | 63 | 2 ans | |
| Jun Yoon | M | 46 | 5 ans | |
| Katey Owen | M | 55 | 3 ans | |
| Stacy Taylor | F | 64 | 5 ans | |
| Ameet Mallik | M | 51 | 3 ans | |
| Maria Grazia Roncarolo | M | 69 | 4 ans | |
| Jeffrey Levitt | M | - | 6 ans | |
| Ted Love | M | 65 | 1 ans | |
| Ramy Farid | M | 59 | 5 ans | |
| David Gionco | M | 63 | 10 ans | |
| Michael Pellini | M | 58 | 6 ans | |
| Matthew Fust | M | 59 | 10 ans | |
| Sharon Tetlow | F | 64 | 2 ans | |
| William Heiden | M | 64 | 9 ans | |
| Dan Maziasz | M | - | 6 ans | |
| Tony Peng | M | - | - | |
| Ying Li Ma | M | 50 | 2 ans | |
| Xi Chen Lin | M | 50 | 5 ans | |
| Natasha Hernday | F | 52 | 13 ans | |
| Mark Bach | M | 67 | 3 ans | |
| Jill Henrich | F | - | - | |
| Francis Lo | M | 43 | 5 ans | |
| Lani Ibarra | F | - | - | |
| Anhco Nguyen | M | 51 | 3 ans | |
| K. Murugan | M | 49 | 4 ans | |
| Karen S. Wright | F | 69 | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| R. Adams | M | 57 | 3 ans | |
| Isaac E. Ciechanover | M | 53 | 7 ans | |
| Felix Baker | M | 55 | 20 ans | |
| Mina Kim | F | 50 | 1 ans | |
| Darren Cline | M | 59 | 9 ans | |
| Edmon R. Jennings | M | 75 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 6 ans |
| Joshua Brumm | M | 46 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 4 ans |
| Vaughn Himes | M | 63 | 14 ans | |
| Joseph Newell | M | 54 | 5 ans | |
| Colin Hislop | M | 66 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 1 ans |
| Andris A. Zoltners | M | 78 | 11 ans | |
| John Orwin | M | 62 | 9 ans | |
| John Craighead | M | - | - | |
| Nancy Hill | F | 60 | 8 ans | |
| Andrew King | M | 44 | 4 ans | |
| Charles Sang | M | 56 | 7 ans | |
| Kirk D. Schumacher | M | - | 11 ans | |
| David Goel | M | 54 | 5 ans | |
| Marcos Milla | M | 61 | 1 ans | |
| Larry K. Benedict | M | 63 | 8 ans | |
| Robert Azelby | M | 56 | - | |
| Charles Romp | M | - | 13 ans | |
| Christopher Boerner | M | 53 | 5 ans | |
| Beth Seidenberg | M | 67 | 11 ans | |
| James Kyle Bryan | M | - | - | |
| Dolca Thomas | M | 53 | 3 ans | |
| Shane Ward | M | 49 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 3 ans |
| Krishnan Mahesh /davita/ | - | - | - | |
| Tina Gullotta | F | 50 | 4 ans | |
| Tony Sun | M | 52 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 5 ans |
| Roy Baynes | M | 69 | 4 ans | |
| Shay Shemesh | M | 41 | 5 ans | |
| Kevin Haas | M | 59 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 4 ans |
| Franklin Berger | M | 74 | 10 ans | |
| Jean Liu | F | 55 | 9 ans | |
| Leslie Trigg | F | 53 | - | |
| Kevin Conroy | M | 58 | 4 ans | |
| Obi Greenman | M | 57 | 13 ans | |
| Heather Turner | F | 51 | 3 ans | |
| J. Buchi | M | 69 | 4 ans | |
| Eckard Weber | M | 73 | 2 ans | |
| David Gryska | M | 68 | 18 ans | |
| Joel Marcus | M | 76 | 6 ans | |
| H. Perry Fell | M | - | 7 ans | |
| Kenneth Lee | M | 76 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | - |
| John McLaughlin | M | 72 | 9 ans | |
| Stephen Hall | M | 73 | - | |
| John Varian | M | 64 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 4 ans |
| Douglas Williams | M | 66 | 3 ans | |
| Robert Hoffman | M | 58 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | - |
| Ronald Renaud | M | 55 | 2 ans | |
| Nancy Simonian | M | 63 | 11 ans | |
| John F. McGrath | M | 59 | 6 ans | |
| Ross Haghighat | M | 60 | 14 ans | |
| Bruce J. Seeley | M | 59 | 3 ans | |
| Alan Glicklich | M | - | 2 ans | |
| Jonathan Drachman | M | 62 | 14 ans | |
| Eric Sievers | M | 60 | 9 ans | |
| Elaine Waller | M | 72 | 10 ans | |
| Brandi Robinson | F | - | 2 ans | |
| Todd Simpson | M | 63 | 18 ans | |
| Jorge Cerda Lucero | M | - | - | |
| Amy P. Sing | M | 65 | 4 ans | |
| Andrew Sandler | M | 58 | 4 ans | |
| Iqbal S. Grewal | M | - | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 100 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Eric Dobmeier
- Réseau Personnel
